Krishnamoorthy Satheesh

About

I hold a Doctor of Medicine degree in Pharmacology, a Master of Medicine degree in Family Medicine, and a Ph.D. in Basic Medical Science from Dr. Tamil Nadu Dr. M.G.R. Medical University. I have undergone specialized training in Clinical Trials, Biostatistics, Epidemiology, and Public Health Aspects of Diabetes Mellitus from various prestigious institutions, including the University of Cambridge.

I have conducted several multicentric studies, from conceptualization to publication, and have published over 30 articles and chapters in indexed journals. I have collaborated with several foreign universities, including Clinical Diabetes and Epidemiology and Baker I.D.I. Heart, Diabetes Institute in Melbourne, Australia, Amsterdam University, Cambridge University, and Imperial College London, for various data analysis projects.

I am an Associate Professor and Senior Research Scientist at India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals in Chennai. I have conducted epidemiology surveys in various parts of Tamil Nadu and have been a Co-Investigator in several Phase IV clinical trials conducted by multiple pharmaceutical companies. I have created electronic health records for my research studies.

I am the Member Secretary and Academic Officer of the India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals in Chennai and have been a core member in the creation and execution of India's first diabetes digital platform, "Diahome." This platform provides digital treatment for diabetes patients across India. My primary areas of interest include epidemiology, primary prevention, diabetes, and digital health. I have collaborated with WHO and the Ministry of Health and Family Welfare, India, for a digital health program for Diabetes.

Employment

• Dr. A. Ramachandran's Diabetes Hospitals Senior Research Scientist
  2012 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (30)

• A prospective, multicentre, randomized, open-label comparison of a long-acting basal insulin analog glargine plus glulisine with premixed insulin in insulin naïve patients with Type 2 diabetes – A study from India
  Primary Care Diabetes 2024 DOI: 10.1016/j.pcd.2024.01.006
  +Save
• Improvement in glycaemic control in patients with type 2 diabetes with treatment using an interactive mobile application – A pilot study from India
  Primary Care Diabetes 2022 DOI: 10.1016/j.pcd.2022.10.008
  +Save
• Serum and salivary adipokines in type 2 diabetes – Results of a pilot study in India
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2022 DOI: 10.1016/j.dsx.2022.102536
  +Save
• 1129-P: Rising Prevalence of Type 2 Diabetes in the Young in Southern India
  Diabetes 2022 DOI: 10.2337/db22-1129-p
  +Save
• 968-P: Improvement in Glycaemic Control and Cost of Diabetes Care Using Diahome, a Smartphone Application
  Diabetes 2022 DOI: 10.2337/db22-968-p
  +Save
• Concordance in incidence of diabetes among persons with prediabetes detected using either oral glucose tolerance test or glycated haemoglobin
  Primary Care Diabetes 2022 DOI: 10.1016/j.pcd.2022.02.004
  +Save
• Analysis of an Indian diabetes prevention programme on association of adipokines and a hepatokine with incident diabetes
  Scientific Reports 2021 DOI: 10.1038/s41598-021-99784-x
  +Save
• Secular trends in cardiovascular risk factors among urban and rural populations in Tamil Nadu, India – An ancillary analysis of the STRiDE-I study
  Diabetes Research and Clinical Practice 2021 DOI: 10.1016/j.diabres.2021.108930
  +Save
• Profile and prognosis of patients hospitalized for COVID-19 virus infection with and without diabetes – An observational study from South India
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2021 DOI: 10.1016/j.dsx.2021.05.016
  +Save
• 425-P: Association between Neuropathy and Periodontitis among Type 2 Diabetes Patients
  Diabetes 2021 DOI: 10.2337/db21-425-p
  +Save